Poolbeg Pharma PLC (AIM:POLB)
London · Delayed Price · Currency is GBP · Price in GBX 6.15
0.00 (0.02%)
Jul 24, 2026, 3:08 PM GMT
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 46.95 million as of July 24, 2026. Its market cap has increased by 117.23% in one year.
Market Cap
46.95M
Enterprise Value
39.24M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.15
ChartMarket Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 46.95M, a decrease of -12.65%. That is a compound annual growth rate of -2.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 46.95M | 68.36% |
| Dec 31, 2025 | 27.89M | -21.44% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
| Jul 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 108.97M |
| Faron Pharmaceuticals Oy | 91.98M |
| 4basebio | 81.58M |
| Bioventix | 80.99M |
| Ondine Biomedical | 71.44M |
| hVIVO | 46.37M |
| Hemogenyx Pharmaceuticals | 45.97M |
| Sareum Holdings | 32.56M |